PharmaCyte Biotech, Inc. - Common Stock (NQ:PMCB)

0.3901 -0.0100 (-2.50%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PharmaCyte Biotech, Inc. - Common Stock

< Previous 1 2 3 4 Next >

PMCB Stock: 14 Things to Know About PharmaCyte Biotech as Shares Skyrocket ↗

August 18, 2021

PharmaCyte Biotech (PMCB) stock is taking off Wednesday and there are a few things that potential investors need to know about the company.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 18, 2021

Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 71.92% to $5.88 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.4...

Via Benzinga

PharmaCyte Biotech Releases Statement on Nasdaq Uplisting and Current Business Focus

August 16, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 16, 2021

Gainers ADMA Biologics (NASDAQ:ADMA) stock rose 18.79% to $1.77 during Monday's pre-market session. The company's market cap stands at $226.8 million. The company...

Via Benzinga

66 Biggest Movers From Yesterday ↗

August 18, 2021

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 13, 2021

Gainers Cellect Biotechnology (NASDAQ:APOP

Via Benzinga

78 Biggest Movers From Friday ↗

August 16, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 13, 2021

Gainers Biolase (NASDAQ:BIOL) stock increased by 38.01% to $0.87 during Friday's regular session. Trading volume for this security as of 12:35 EST is 80.8 million,...

Via Benzinga

53 Stocks Moving In Friday's Mid-Day Session ↗

August 13, 2021

Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said it continues to experience demand...

Via Benzinga

Mid-Morning Market Update: Markets Edge Higher; Disney Reports Upbeat Q3 Earnings ↗

August 13, 2021

Following the market opening Friday, the Dow traded up 0.04% to 35,512.89 while the NASDAQ rose 0.20% to 14,845.17. The S&P also rose, gaining 0.11% to 4,465.85. The U.S. has...

Via Benzinga

Topics Stocks

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

77 Biggest Movers From Yesterday ↗

August 13, 2021

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to...

Via Benzinga

PharmaCyte Biotech Announces Closing of $15-Million Public Offering

August 12, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗

August 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

PharmaCyte Biotech Announces Uplist Date to NASDAQ and Pricing of $15 Million Public Offering

August 09, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Announces Uplist to The Nasdaq Capital Market and Launch of Public Offering

August 02, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Announces Update on Study Progress and Uplist to Nasdaq

July 14, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Announces Stability Test Results on Cells from Master Cell Bank

July 13, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Announces Stability Test Results on Cells from Master Cell Bank

July 12, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Announces Reverse Stock Split

July 09, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Announces Results of Vote at Annual Meeting of Stockholders

July 08, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Provides Update on Status of Activities to Lift Clinical Hold

June 24, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Announces Shareholders Vote to Increase the Authorized Capital

June 22, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Announces Adjournment of Annual Meeting of Stockholders, Recording of Stockholder Meeting Available

June 18, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

PharmaCyte Biotech Announces Details to Attend This Week’s Virtual Annual Meeting of Shareholders

June 14, 2021

From PharmaCyte Biotech, Inc.

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.